CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes President and CEO gave up 863 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 370 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 370 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 493 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Reg & Develop Officer gave up 357 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 288 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 372,093 shares at $10.75 ($4,000,000)
- 4 Open-market buy Director bought 7,100 shares at $14.00 ($99,370)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 6,600 shares at $15.00 ($98,985)
- 4 Open-market buy Director bought 6,250 shares at $15.97 ($99,813)
- 4 Open-market sale Chief Legal Officer sold 5,000 shares at $20.00 ($100,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 10,000 shares at $20.00 ($200,000)
- 4 Open-market buy Director bought 500 shares at $19.12 ($9,560)
Page 15 of 21 · 414 filings